Pancreatic Cancer Research

ResearcherTongji UniversityActive in the last 2 years

Zhaoshen Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9200-8701; OpenAlex author ID A5100733345. Sources: OpenAlex.

Their work

Papers
13 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
59
Papers, trials and grants by year

2012: 1 paper · 2013: 2 papers · 2014: 1 paper · 2015: 1 paper · 2016: 2 papers · 2017: none · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 13

  1. MKLN1-AS promotes pancreatic cancer progression as a crucial downstream mediator of HIF-1α through miR-185-5p/TEAD1 pathway. Co-author DOI 10.1007/s10565-024-09863-8↗
  2. Downregulation of GSTM2 enhances gemcitabine chemosensitivity of pancreatic cancer in vitro and in vivo. Co-author DOI 10.1016/j.pan.2020.12.008↗
  3. Erratum: Downregulation of miR-486-5p Enhances the Anti-Tumor Effect of 5-Fluorouracil on Pancreatic Cancer Cells [Corrigendum]. Last author DOI 10.2147/ott.s259765↗
  4. VDR signaling inhibits cancer-associated-fibroblasts' release of exosomal miR-10a-5p and limits their supportive effects on pancreatic cancer cells. Co-author DOI 10.1136/gutjnl-2018-316627↗
  5. MicroRNA-132 Plays an Independent Prognostic Role in Pancreatic Ductal Adenocarcinoma and Acts as a Tumor Suppressor. Co-author DOI 10.1177/1533033818824314↗
  6. HPP1 gene promoter methylation in pancreatic cancer: correlation with carcinogenesis and clinical implication. Last author PMID 31949740↗
  7. Pancreatic cancer risk variant in LINC00673 creates a miR-1231 binding site and interferes with PTPN11 degradation. Co-author DOI 10.1038/ng.3568↗
  8. Hedgehog Signaling Non-Canonical Activated by Pro-Inflammatory Cytokines in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.7150/jca.15786↗
  9. MicroRNA-222 Controls Human Pancreatic Cancer Cell Line Capan-2 Proliferation by P57 Targeting. Co-author DOI 10.7150/jca.12546↗
  10. High neuropilin 1 expression was associated with angiogenesis and poor overall survival in resected pancreatic ductal adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000000117↗
  11. Adenovirus vector-mediated Gli1 siRNA induces growth inhibition and apoptosis in human pancreatic cancer with Smo-dependent or Smo-independent Hh pathway activ… Co-author DOI 10.1016/j.canlet.2013.06.010↗
  12. Lamin B1 is a novel therapeutic target of betulinic acid in pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-12-3630↗
  13. Copy number variation at 6q13 functions as a long-range regulator and is associated with pancreatic cancer risk. Co-author DOI 10.1093/carcin/bgr228↗

Closest collaborators

The 25 strongest of 59 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiangyu Kong · 4 shared papers, 2013–2024 · strength 0.41
  2. Fanyang Kong · 2 shared papers, 2019–2024 · strength 0.32
  3. Jun Gao · 5 shared papers, 2013–2019 · strength 0.27
  4. Jiayu Chen · 1 shared paper, 2024 · strength 0.21
  5. Yuqiong Wang · 3 shared papers, 2015–2019 · strength 0.20
  6. Lu Zhuang · 2 shared papers, 2018–2021 · strength 0.20
  7. Lisi Peng · 2 shared papers, 2018–2021 · strength 0.20
  8. Wei Ting Wang · 1 shared paper, 2020 · strength 0.12
  9. Bowei Liu · 1 shared paper, 2020 · strength 0.12
  10. Xiuling Li · 1 shared paper, 2020 · strength 0.12
  11. Shuangyin Han · 1 shared paper, 2020 · strength 0.12
  12. Lei Li · 1 shared paper, 2019 · strength 0.11
  13. Thiruvengadam Arumugam · 1 shared paper, 2021 · strength 0.11
  14. Haojie Huang · 1 shared paper, 2021 · strength 0.11
  15. Hui Jiang · 1 shared paper, 2021 · strength 0.11
  16. Baoan Ji · 1 shared paper, 2021 · strength 0.11
  17. Craig D. Logsdon · 1 shared paper, 2021 · strength 0.11
  18. Yiqi Du · 1 shared paper, 2019 · strength 0.10
  19. Yan Chen · 1 shared paper, 2019 · strength 0.10
  20. Huiyun Zhu · 1 shared paper, 2019 · strength 0.10
  21. Yang Zhang · 1 shared paper, 2018 · strength 0.08
  22. Kun Lin · 1 shared paper, 2018 · strength 0.08
  23. Kaixuan Wang · 1 shared paper, 2018 · strength 0.08
  24. Haojie Huang · 1 shared paper, 2018 · strength 0.08
  25. Dianke Yu · 2 shared papers, 2012–2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.